PSU general insurance companies report loss of ₹26,364 crore to health portfolio in last 5 years

A CAG report said that all the four public sector insurance companies have incurred a loss of Rs 26,364 crore in the health insurance portfolio in the last five years.

“The loss of health insurance business of PSU insurers either eroded or eroded the profits of other lines of business or increased the overall loss,” said an audit report of the CAG tabled in Parliament recently.

Four PSU insurance companies – New India Assurance Company Limited (NIACL), United India Insurance Company Limited (UICL), Oriental Insurance Company Limited (OICL) and National Insurance Company Limited (NICL) had total losses of ₹26,364 crore during 2016- 17 From 2020-21.

The health insurance business is the second largest line of business of PSU insurers (first motor insurance) with a gross direct premium of ₹1,16,551 crore during the five years 2016-17 to 2020-21.

The report noted that the market share of PSU insurers in the health insurance business is also steadily declining as compared to stand-alone health insurers and private insurers.

The report of the Comptroller and Auditor General (CAG) of India stated that the Finance Ministry has laid down guidelines (September 2012/May 2013) for underwriting group policies, according to which the combined proportion of standalone group policies should not exceed 95%. and if cross-subsidies for group policies are included, the combined ratio will not exceed 100%.

“The audit observed that the Ministry’s guidelines were not complied with by the PSU insurers and the combined proportion of the group health insurance segment as reported by the PSU insurers ranged from 125-165%,” it said.

With regard to claim management, the report said, IT systems in PSU insurance companies lack proper verification checks and controls, which undermines the smooth functioning and reporting system.

This has resulted in lapses like multiple settlement of claims, overpayment of Sum Assured, overpayment due to neglect of waiting period clause for specific diseases, non-applicability of co-payment clause, breach of capping limit for specific diseases . Incorrect valuation of admissible claim amount, irregular payment on transplant, non-payment of interest on delayed settlement etc.